Novo Nordisk Live (@NovoNordiskLive) “ESC and ACC/AHA recognise hsCRP as a modifier and enhancer of CVD risk. Is CV In” — TopicDigg
Novo Nordisk Live
@NovoNordiskLive
加入 September 2012
0 正在关注 0 粉丝
ESC and ACC/AHA recognise hsCRP as a modifier and enhancer of CVD risk. Is CV Inflammation guilty?
